Stratagene and Ariadne Face Arbitration to Settle Spat Over Pathway Assist Distribution Agreement | GenomeWeb

Stratagene and Ariadne Genomics have had a falling out over a 2002 distribution agreement for Ariadne's Pathway Assist software that is due to expire in mid-December.

According to SEC filings and documents filed with the US District Court of the Southern District of California, the companies have each filed a request with the American Arbitration Association in San Diego to settle the dispute, which began in February when Ariadne first accused Stratagene of violating a number of terms of the original agreement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.